National Health Investors Stock Fundamentals
| NHI Stock | USD 75.10 1.73 2.36% |
National Health Investors fundamentals help investors to digest information that contributes to National Health's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National Health stock.
As of now, National Health's EBIT is increasing as compared to previous years. The National Health's current EBITDA is estimated to increase to about 277.4 M, while Depreciation And Amortization is projected to decrease to under 37.8 M. National | Select Account or Indicator |
National Health Investors Company Return On Equity Analysis
National Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current National Health Return On Equity | 0.1 |
Most of National Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Health Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
National Return On Equity Historical Pattern
Today, most investors in National Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various National Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's return on equity growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of National Health return on equity as a starting point in their analysis.
National Health Return On Equity |
| Timeline |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
National Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, National Health Investors has a Return On Equity of 0.1028. This is 107.56% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The return on equity for all United States stocks is 133.16% lower than that of the firm.
National Health Investors Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining National Health's current stock value. Our valuation model uses many indicators to compare National Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across National Health competition to find correlations between indicators driving National Health's intrinsic value. More Info.National Health Investors is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for National Health Investors is roughly 2.22 . As of now, National Health's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the National Health's earnings, one of the primary drivers of an investment's value.National Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Health's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Health could also be used in its relative valuation, which is a method of valuing National Health by comparing valuation metrics of similar companies.National Health is currently under evaluation in return on equity category among its peers.
National Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of National Health from analyzing National Health's financial statements. These drivers represent accounts that assess National Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of National Health's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 3.1B | 2.6B | 2.3B | 2.4B | 3.0B | 3.2B | |
| Enterprise Value | 4.6B | 3.8B | 3.5B | 3.5B | 4.2B | 4.4B |
National Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, National Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to National Health's managers, analysts, and investors.Environmental | Governance | Social |
National Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0463 | ||||
| Profit Margin | 0.41 % | ||||
| Operating Margin | 0.63 % | ||||
| Current Valuation | 4.45 B | ||||
| Shares Outstanding | 45.69 M | ||||
| Shares Owned By Insiders | 4.71 % | ||||
| Shares Owned By Institutions | 70.42 % | ||||
| Number Of Shares Shorted | 2.07 M | ||||
| Price To Earning | 13.23 X | ||||
| Price To Book | 2.44 X | ||||
| Price To Sales | 9.99 X | ||||
| Revenue | 257.05 M | ||||
| Gross Profit | 324.42 M | ||||
| EBITDA | 264.16 M | ||||
| Net Income | 136.64 M | ||||
| Cash And Equivalents | 19.29 M | ||||
| Cash Per Share | 0.97 X | ||||
| Total Debt | 1.15 B | ||||
| Debt To Equity | 0.78 % | ||||
| Current Ratio | 2.78 X | ||||
| Book Value Per Share | 33.73 X | ||||
| Cash Flow From Operations | 207.77 M | ||||
| Short Ratio | 10.24 X | ||||
| Earnings Per Share | 3.13 X | ||||
| Price To Earnings To Growth | 1.99 X | ||||
| Target Price | 80.86 | ||||
| Number Of Employees | 30 | ||||
| Beta | 1.12 | ||||
| Market Capitalization | 3.35 B | ||||
| Total Asset | 2.61 B | ||||
| Retained Earnings | 2.6 B | ||||
| Working Capital | (17.44 M) | ||||
| Current Asset | 73.06 M | ||||
| Current Liabilities | 52.78 M | ||||
| Annual Yield | 0.05 % | ||||
| Five Year Return | 6.01 % | ||||
| Net Asset | 2.61 B | ||||
| Last Dividend Paid | 3.6 |
About National Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Health Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Health Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 4.3 M | 4.6 M | |
| Total Revenue | 257 M | 174.1 M | |
| Cost Of Revenue | 11.2 M | 10.6 M | |
| Stock Based Compensation To Revenue | 0.02 | 0.01 | |
| Sales General And Administrative To Revenue | 0.08 | 0.04 | |
| Capex To Revenue | 0.01 | 0.01 | |
| Revenue Per Share | 5.86 | 4.08 | |
| Ebit Per Revenue | 0.84 | 0.70 |
Currently Active Assets on Macroaxis
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out National Health Piotroski F Score and National Health Altman Z Score analysis. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 3.13 | Revenue Per Share | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.